• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMET UK LTD. DELTA CER FEM HD 28/-3MM T1; BIOLOX DELTA CERAMIC FEM HD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMET UK LTD. DELTA CER FEM HD 28/-3MM T1; BIOLOX DELTA CERAMIC FEM HD Back to Search Results
Model Number N/A
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Pulmonary Embolism (1498)
Event Date 03/02/2022
Event Type  Injury  
Manufacturer Narrative
(b)(4).Initial report.Report source, foreign - event occurred in (b)(6).The client has indicated that the product will not be returned to zimmer biomet for an investigation.Associated products: medical product: tprlc 133 fp type1 pps so 8.0.Catalogue number: 51-100080.Lot number: unknown.Medical product: e1 ringloc bipolar 28x46mm.Catalogue number: 110010465.Lot number: unknown.The investigation is currently underway.Once the investigation has concluded, a follow-up mdr will be submitted.Remains implanted.
 
Event Description
It was reported, that: on 02-mar-2022, a journal article was retrieved from the journal of orthopaedic surgery (2021) that reported a study from japan that looked at the impact of the surgical approach on postoperative dislocations.The purpose of the study was to evaluate the efficacy and safety of hemiarthroplasty performed using the cpp (conjoined tendon preserving posterior) approach for femoral neck fractures.The study reviewed 322 patients with femoral neck fractures.A bipolar hemiarthroplasty was performed in all patients using a press-fit taperloc stem and ringloc bipolar cup.Two patients were excluded from the study due to receiving a total hip at the time of surgery, leaving 320 patients for final review.No patients were excluded based on age, frailty, or cognitive status.The study population had a mean age of 83.3 years at the time of surgery (range 57-104) and a mean bmi of 20.7 (range 11.4-28.9).The final follow-up was conducted at 9.1 +/- 1.5 months after surgery (range 6-17 months).Complaint 7: the study reported an initial right hip hemiarthroplasty performed on (b)(6) 2018 on a (b)(6) female.After closing the wound during the initial procedure, the patient developed low cardiac output and oxygen levels.The patient was subsequently diagnosed with a pulmonary embolism.The pe was noted to have resolved.No further details have been provided.
 
Event Description
It was reported, that: on 02-mar-2022, a journal article was retrieved from the journal of orthopaedic surgery (2021) that reported a study from japan that looked at the impact of the surgical approach on postoperative dislocations.The purpose of the study was to evaluate the efficacy and safety of hemiarthroplasty performed using the cpp (conjoined tendon preserving posterior) approach for femoral neck fractures.The study reviewed 322 patients with femoral neck fractures.A bipolar hemiarthroplasty was performed in all patients using a press-fit taperloc stem and ringloc bipolar cup.Two patients were excluded from the study due to receiving a total hip at the time of surgery, leaving 320 patients for final review.No patients were excluded based on age, frailty, or cognitive status.The study population had a mean age of 83.3 years at the time of surgery (range 57-104) and a mean bmi of 20.7 (range 11.4-28.9).The final follow-up was conducted at 9.1 +/- 1.5 months after surgery (range 6-17 months).Complaint 7: the study reported an initial right hip hemiarthroplasty performed on 26-jan-2018 on a 72-year-old female.After closing the wound during the initial procedure, the patient developed low cardiac output and oxygen levels.The patient was subsequently diagnosed with a pulmonary embolism.The pe was noted to have resolved.No further details have been provided.Patient involved.
 
Manufacturer Narrative
(b)(4).This final report is being submitted to relay supplemental information.Complaint summary: adequate photographs have not been provided and product the has not been returned for evaluation.Therefore, the investigation has been limited to the information provided and a complaint history search.No dhr review is possible as the lot number is unknown.This device is used for treatment.The reported event is not related to a combination of products; therefore, a compatibility review is not applicable.A review of complaint history identified no additional similar complaints about the reported item and no additional complaints about the reported item and lot combination.Medical records or x-rays are not relevant for this event.The likely condition of the device when it left zimmer biomet is conforming to the specification.The reported event has not been confirmed as relevant photographs have not been provided and the product has not been returned for evaluation.The definitive root cause of this event cannot be determined with the available information.It could not be confirmed that the implant is within the scope or subject of any field actions or recalls which could be attributed to the reported event as the lot number is unknown.Corrective or preventative action is not required as the root cause of the reported event cannot be determined with the information provided.If any additional information is discovered or received that may adjust any conclusions or data, a supplemental report will be rendered accordingly.Zimmer biomet will continue to monitor for trends.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DELTA CER FEM HD 28/-3MM T1
Type of Device
BIOLOX DELTA CERAMIC FEM HD
Manufacturer (Section D)
BIOMET UK LTD.
waterton industrial estates
bridgend CF31 3XA
UK  CF31 3XA
Manufacturer (Section G)
BIOMET UK LTD.
waterton industrial estates
bridgend CF31 3XA
UK   CF31 3XA
Manufacturer Contact
christina arnt
56 e. bell dr.
warsaw, IN 46582
5745273773
MDR Report Key14315851
MDR Text Key291836684
Report Number3002806535-2022-00237
Device Sequence Number1
Product Code LZO
UDI-Device Identifier00887868271533
UDI-Public00887868271533
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K192683
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature,Health Professional,User Facility
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 05/24/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberN/A
Device Catalogue Number650-1159
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 04/27/2022
Initial Date FDA Received05/07/2022
Supplement Dates Manufacturer Received05/23/2022
Supplement Dates FDA Received05/24/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Removal/Correction NumberN/A
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
Patient Age72 YR
Patient SexFemale
Patient Weight60 KG
-
-